Figure 4
Figure 4. TNT003 prevents CA-mediated hRBC lysis and anaphylatoxin generation. (A) hRBCs exposed to CAD plasma sample P5 followed by 25% NHS exhibited complement-dependent hemolysis that was inhibited by TNT003, but not IC, in a concentration-dependent manner (IC50 = 5.1 μg/mL; 34 nM). Supernatant from these experiments was assayed for C4a (B; IC50 = 5.2 μg/mL; 35 nM), C3a (C; IC50 = 5.2 μg/mL; 35 nM), and C5a (D; IC50 = 4.9 μg/mL; 33 nM) by plate-based ELISA. Data are normalized to control (P5 plasma plus 25% NHS) and depict the average of 3 experiments.

TNT003 prevents CA-mediated hRBC lysis and anaphylatoxin generation. (A) hRBCs exposed to CAD plasma sample P5 followed by 25% NHS exhibited complement-dependent hemolysis that was inhibited by TNT003, but not IC, in a concentration-dependent manner (IC50 = 5.1 μg/mL; 34 nM). Supernatant from these experiments was assayed for C4a (B; IC50 = 5.2 μg/mL; 35 nM), C3a (C; IC50 = 5.2 μg/mL; 35 nM), and C5a (D; IC50 = 4.9 μg/mL; 33 nM) by plate-based ELISA. Data are normalized to control (P5 plasma plus 25% NHS) and depict the average of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal